Darragh Fitzpatrick’s new colleague lives in a cloud. He’s smart. He’s easy to work with. And he never sleeps. Ever. He works 24 hours a day in research labs around the world – and recently turbo-charged the development of 3D printed nasal swabs for COVID-19 testing. His name’s Albert. He’s new to Henkel. And it’s time you get to know him.
Albert around the Henkel world
Albert is now supporting in different areas and functions on the Henkel sites worldwide. “The initial introduction of Albert was exclusively for the 3D printing business, where it was piloted in Dublin and Düsseldorf, but it’s now also supporting product development at our site in Irvine, California, which serves the electronics industry,” Darragh explains. Albert’s global footprint will expand even further in our new Innovation Center in Düsseldorf where it will first be used for inventory management,” Darragh says. Albert is evolving, too, and it’s exciting for users to input directly to its upgrades. A new user interface has just been released with more functions and improved visual interaction and aesthetics. “It’s great to see Albert settling in at Henkel – and we’re all excited about working with him for many years to come,” Darragh points out.
16,000 formulations were reviewed by Albert to find the best available material for the 3D printed swabs.
3 days was all Henkel and Origin needed to design and produce a prototype.
500,000 swabs are now being produced each week.
As of today, there are more than 700,000 data points, collected from over 30,000 experiments, stored in Albert and this is growing exponentially each day, as new experiments are conducted.